Tratamiento con insulina aspártica bifásica en pacientes con diabetes en mal control metabólico: Experiencia clínica programada
Background: Biophasic insulin aspart (InAsBi) is a mixture of 30% of rapid acting soluble aspart insulin and 70% aspart insulin retarded with protamine. The soluble portion reduces postprandial serum glucose rises and the retarded portion reduces basal glucose levels. Aim: To assess the efficacy of...
Saved in:
| Main Authors: | , , |
|---|---|
| Language: | Spanish / Castilian |
| Published: |
Sociedad Médica de Santiago
2007
|
| Subjects: | |
| Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007001000004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|